Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
72 /100
HIGH RISK
Score updated Oct 13, 2026

MDCX — Medicus Pharma Ltd. Dilution Risk Tracker

Track MDCX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MDCX — Get alerts when the score changes →

As of October 13, 2026, Medicus Pharma Ltd. (MDCX) has a DilutionWatch DilutionScore of 72/100, rated HIGH dilution risk. Medicus Pharma Ltd. has a market capitalization of $226.19M, 63.18M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $8.04M, ATM program capacity of $50.00M, 1.12M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
85
📊 Float Risk
20
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 59%
💰 Capital Raise model 73%
• Low cash runway: 6 months remaining
• Active shelf registration ($8M, 4% of market cap)
🔄 Reverse Split model est. 70%
• 50-day avg $0.36 below $1 exchange minimum
• Only 6 months cash — financial pressure
📉 Score Deterioration model 10%
• Score in HIGH risk zone (72/100)
🔔 Track MDCX — Get forecast alerts →

Market Data

Market Cap$226.19M
Shares Outstanding63.18M
Float50.14M
Cash$15.17M
Debt$2.34M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore72/100DilutionWatch score record
Shares Outstanding63.18MVerified float table or market cache
Public Float50.14MVerified float table or market cache
Market Cap$226.19MMarket data cache
Cash Runway5.7 monthsDilutionWatch score inputs
Shelf Capacity$8.04MSEC-derived dilution fields
ATM Capacity$50.00MSEC-derived dilution fields
Outstanding Warrants1.12MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 1, 424B3 2, 8-K 1, SC 13D 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

10 institutional holders · 3.93M shares
#1 Armistice Capital, LLC 1.81M shares
#2 Interchange Capital Partners, LLC 1.66M shares
#3 Private Advisor Group, LLC 175.5K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.69M
Days to Cover1.0
% of Float7.3%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-25
xbrl XBRL WARRANT 2026-03-25
424B3 ATM 2026-10-07
SC 13D BENEFICIAL OWNERSHIP 2026-09-14
424B3 ATM 2026-09-14
Full SEC filing analysis available with free account →

Recent News

Factual MDCX Dilution Snapshot

Medicus Pharma Ltd. (MDCX) has a DilutionScore of 72/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

MDCX's DilutionScore is currently 72/100 (High risk), with 5 score changes tracked over 89 days. The score deteriorated from 77/100 (Critical risk).

Period Score Risk Level Duration
Oct 13, 202672/100HIGH1 day
Oct 08 – Oct 12, 202677/100CRITICAL5 days
Oct 01 – Oct 07, 202673/100HIGH7 days
Sep 28 – Sep 30, 202667/100HIGH3 days
Aug 14 – Sep 27, 202671/100HIGH44 days
Jul 16 – Aug 13, 202675/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

MDCX shares outstanding have increased 123.3% from 24.71M (Mar 2026) to 55.16M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 16, 202655.16M50.14M▲ 43.94%
May 15, 202655.16M34.84M▲ 4.33%
May 11, 202655.16M33.39M▲ 0.85%
May 10, 202655.16M33.11M▼ 0.28%
Mar 27, 202629.74M28.22M▲ 78.68%
Mar 14, 202624.71M15.79M▲ 6.52%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track MDCX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment MDCX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking MDCX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for MDCX
MDCX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.